- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0004088

Adivis Pharma Private Limited
About Adivis Pharma Private Limited
Data last updated:
Adivis Pharma Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC382288.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Lalit Wadhwa and Rohit Valecha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P No – 19 – Wz – 5 – A – 1 Vishnu Garden, Delhi, India – 110018.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.47 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹7.93 Lakh (net margin 1.2%) and EBITDA of ₹12.99 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 141% over three years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
Adivis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0004088). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Adivis Pharma
Contact details
Adivis Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressP No – 19 – Wz – 5 – A – 1 Vishnu Garden, Delhi, India – 110018
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adivis Pharma is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
To see the full business activity and turnover split of Adivis Pharma Private Limited, buy the company report.
Financials of Adivis Pharma Private Limited
FY 2025 filings availableAdivis Pharma Private Limited reported revenue of ₹6.47 Cr (up 53% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 141% over three years, including 53% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹12.99 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹7.93 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2% | |||
| Net Profit Margin | 1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Adivis Pharma Private Limited, buy the company report.
Board of directors of Adivis Pharma Private Limited
Adivis Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalit Wadhwa | Director | 15 Jun 2021 | 5 Years 4 Months | Current |
| Rohit Valecha | Director | 15 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Adivis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (plastic products, non-metallic mineral products, rubber products, fabricated metal products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Morgan Industries Limited | ₹6.48 Cr (FY 2025) | -6.0% | Tamil Nadu, India | |||
| Sri Krishna Pyro Exports Private Limited | ₹6.48 Cr (FY 2024) | 26.0% | Sivakasi, Tamil Nadu, India | |||
| Kamacom Systems Private Limited | ₹6.47 Cr (FY 2025) | 61.0% | Goa, India | |||
| Reliable Belting India Private Limited | ₹6.47 Cr (FY 2025) | 26.0% | Jaipur, Rajasthan, India | |||
| Parshwanath Polymers Private Limited | ₹6.47 Cr (FY 2024) | -7.0% | Indore, Madhya Pradesh, India | |||
| Adivis Pharma Private Limitedthis company | ₹6.47 Cr (FY 2025) | ₹7.93 Lakh | 1.2% | 53.0% | Delhi, India | |
| Ganix Rubber Recycling Private Limited | ₹6.46 Cr (FY 2025) | -27.0% | Faridabad, Haryana, India | |||
| Resonant Plast Private Limited | ₹6.46 Cr (FY 2025) | 11.0% | Nashik, Maharashtra, India | |||
| Grip Tight Shrink Films Private Limited | ₹6.46 Cr (FY 2025) | 33.0% | Nagpur, Maharashtra, India | |||
| Shashi Fluoroplastiks Private Limited | ₹6.44 Cr (FY 2025) | 6526.0% | Vasai, Maharashtra, India | |||
| Fabil Qualipack Private Limited | ₹6.44 Cr (FY 2024) | -26.0% | Gangapur, Maharashtra, India |
To see the full peer comparison of Adivis Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2023 | 100687242 | Others | ₹1 Cr | Open |
To see the full charge records of Adivis Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Adivis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adivis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Adivis Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Adivis Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Lalit Wadhwa was appointed as Director on 15 Jun 2021.
Frequently asked questions
Adivis Pharma is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 June 2021 (5+ years old) and is registered under CIN U24290DL2021PTC382288.
Adivis Pharma has 2 current directors:
- Lalit Wadhwa - Director
- Rohit Valecha - Director
The latest financial statements of Adivis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Adivis Pharma is U24290DL2021PTC382288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adivis Pharma was incorporated on 15 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Adivis Pharma by revenue are Morgan Industries Limited, Sri Krishna Pyro Exports Private Limited, Kamacom Systems Private Limited, Reliable Belting India Private Limited, Parshwanath Polymers Private Limited and 5 more, all in the same principal business activity (plastic products, non-metallic mineral products, rubber products, fabricated metal products).
Lalit Wadhwa was appointed as Director on 15 Jun 2021. Rohit Valecha was appointed as Director on 15 Jun 2021.
Yes, Adivis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0004088).
The registered office of Adivis Pharma is at P No – 19 – Wz – 5 – A – 1 Vishnu Garden, Delhi, India – 110018.
Adivis Pharma operates in the chemicals industry, in the manufacturing segment.
Adivis Pharma has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.

